← Leaderboards
Richard L Thompson
University Of Cincinnati
$4,885,795
Attributed
$5,701,876
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $859.9K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$5,701,876 · 3
By mechanism
R01$4,366,119 · 1
RC1$889,218 · 1
R21$446,539 · 1
Top collaborators
- Nancy M. Sawtell4 shared
- Malak Y.S. Kotb2 shared
Most similar at University Of Cincinnati
Same institution · by research overlap
- Chia-Yang Liu$8,052,846
Others in their field
Top investigators on “Virulence”
- Ronald B Corley · Boston University Medical Campus$43,000,000
- Joseph Heitman · Duke University$29,765,716
- Vanessa Sperandio · University Of Wisconsin-Madison$29,177,087
- Adolfo Garcia-Sastre · Jackson Laboratory$28,883,338
- John J Mekalanos · Harvard Medical School$28,747,360
- Scott J Hultgren · Washington University$28,322,020
Research focus
VirulenceNeuronsPhenotypeMutantLatent InfectionSimplexvirusIn VivoInsightProtein ExpressionViralPathogenComplexPathway InteractionsInfectionVirusCessation Of LifeVirus DiseasesGene ExpressionEye DiseasesBaseLeadLaboratory MouseLatent VirusMicrornas
Grant awards (15)
Revealing networks targeted by HSV-1 ncRNAs with in vivo gain-of-function studies$196,250
R21 · FY2016 · AI · contact PI
Revealing networks targeted by HSV-1 ncRNAs with in vivo gain-of-function studies$250,289
R21 · FY2015 · AI · contact PI
Ocular HSV Infection-Latency and Pathogenesis$425,884
R01 · FY2011 · EY · contact PI
Unbiased Forward Genetic Analysis of Virus/Host Interactions$436,320
RC1 · FY2010 · AI
Ocular HSV Infection-Latency and Pathogenesis$414,189
R01 · FY2010 · EY · contact PI
Unbiased Forward Genetic Analysis of Virus/Host Interactions$452,898
RC1 · FY2009 · AI
Ocular HSV Infection-Latency and Pathogenesis$406,974
R01 · FY2009 · EY · contact PI
Ocular HSV Infection-Latency and Pathogenesis$395,906
R01 · FY2008 · EY · contact PI
Ocular HSV Infection-Latency and Pathogenesis$419,323
R01 · FY2006 · EY · contact PI
Ocular HSV Infection-Latency and Pathogenesis$416,626
R01 · FY2005 · EY
Ocular HSV Infection-Latency and Pathogenesis$404,217
R01 · FY2004 · EY
Ocular HSV Infection-Latency and Pathogenesis$404,767
R01 · FY2003 · EY
OCULAR HSV INFECTION-LATENCY AND PATHOGENESIS$361,591
R01 · FY2002 · EY
OCULAR HSV INFECTION-LATENCY AND PATHOGENESIS$362,558
R01 · FY2001 · EY
OCULAR HSV INFECTION-LATENCY AND PATHOGENESIS$354,084
R01 · FY2000 · EY